Title
Category
Credits
Event date
Cost
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Lauren M.B. Burke, MD, and Katrina A. McGinty, MD, provide an overview of different imaging modalities for imaging the abdomen, as well as some of their common indications and patient-specific limitations. They will also discuss an overview of commonly used imaging modalities with an emphasis on understanding different modalities' strengths and limitations. The goal is to provide instruction on deciding when different imaging modalities and tests are appropriate for different pathologies.
Using Acceptance and Commitment Therapy to Help Cancer Survivors Move Forward After Treatment - SPOC
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Cancer survivors may face many unique psychosocial challenges. Melissa Holt, DNP, PMHNP-BC and Lisa Kanser, PsyD discuss Acceptance and Commitment Therapy (ACT) is an evidence-based psychotherapeutic approach that can effectively teach patients skills to manage these challenges after completing cancer treatment. We will take you through case vignettes to show you how ACT can be applied to this patient population.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Taking a deeper dive into the most common oncologic emergencies facing oncology patients. We will discuss the clinical manifestations, diagnosis, treatment, and prevention of Neutropenic Fever, Tumor Lysis Syndrome, and Cord Compression. These topics are good refreshers for APPs practicing in primary care, urgent, emergency medicine, hematology/oncology, and inpatient medicine.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Nancy Vogler, AGPCNP-BC, will discuss the common types of anemia and thrombocytopenia, common causes of each, how the non-hematology provider can best manage patients with anemia and/or thrombocytopenia, and when to refer to hematology.
- Advanced Practice Provider
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Oral oncolytics have revolutionized cancer care over the last two decades. Although they provide a more convenient & often more tolerable alternative to traditional chemotherapy agents, their unique mechanisms of action lead to a wide range of potential side effects. In this CPP panel discussion, Aimee Faso, Bianka Patel, and Kevin Chen will discuss the considerations when managing side effects for patients receiving oral oncolytic treatments for various solid tumor and hematologic malignancies.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Tracy Vernon-Platt, DNP, ANP-BC, will provide a systematic approach to EKG interpretation. It will also discuss common arrhythmias in patients with cancer, identification of the arrhythmias, and management strategies.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Tammy Triglianos, DNP, ANP-BC, AOCNP, and Mary Dunn, MSN, RN, OCN, NP-C, will highlight the multifaceted challenges faced by cancer survivors and emphasize the importance of personalized care. By examining the physical, emotional, and social needs that evolve over time, they will discuss strategies for approaches to care, including interdisciplinary collaboration, to improve quality of life.
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will go into more detail for treatment options and considerations for treating localized prostate cancer and the management of side effects.
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will provide a general overview of Prostate Cancer. The audience will learn about basic pathophysiology and epidemiology as it relates to both local and advanced disease. This course will then provide insight into the pros & cons of prostate cancer screening as well as the accepted diagnostic procedures & scoring.
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
In this course, Mary Dunn, MSN, RN, NP-C, OCN, will discuss the different treatment options for advanced prostate cancer as well as considerations for management side effects and maximizing a survivor’s quality of life.